PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Mecillinam→

Mecillinam PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
32887-01-7
Molecular formula
C15H23N3O3S
Molecular weight
325.4 g/mol
Drug class
Amidinopenicillin beta-lactam antibacterialpreferential PBP2 inhibitor
Mechanism of action
Binds penicillin-binding protein 2 (PBP2), inhibiting bacterial cell-wall peptidoglycan synthesis and producing bactericidal activity, particularly against susceptible Enterobacterales.
Indications / reported uses
  • Treatment of uncomplicated urinary-tract infection caused by susceptible organisms, particularly Escherichia coli, in countries where oral pivmecillinam is authorised; the oral prodrug formulation and its dose are product-specific

Sources: NLM MeSH — Mecillinam · NICE — Urinary tract infection (lower): antimicrobial prescribing · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Mecillinam PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Mecillinam Permitted Daily Exposure (PDE) report (the Mecillinam PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Mecillinam Occupational Exposure Limit (OEL) report (the Mecillinam OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.